These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34838142)

  • 1. Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report.
    Riis SST; Joergensen MH; Rasmussen KF; Husby S; Hasselby JP; Borgwardt L; Brusgaard K; Fagerberg CR; Christesen HT
    J Med Case Rep; 2021 Nov; 15(1):573. PubMed ID: 34838142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis.
    Ayenew AA
    Matern Health Neonatol Perinatol; 2021 Feb; 7(1):8. PubMed ID: 33531050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
    Gudlaugsson B; Hjartardottir H; Svansdottir G; Gudmundsdottir G; Kjartansson S; Jonsson T; Gudmundsson S; Halldorsdottir AM
    Transfusion; 2020 Jan; 60(1):175-183. PubMed ID: 31850521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic disease of the newborn due to isoimmunization with anti-E antibodies: a case report.
    Sarici SU; Alpay F; Yeşilkaya E; Ozcan O; Gökçay E
    Turk J Pediatr; 2002; 44(3):248-50. PubMed ID: 12405439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated hyperbilirubinemia among infants with hyperinsulinemic hypoglycemia.
    Edwards M; Falzone N; Harrington J
    Eur J Pediatr; 2021 May; 180(5):1653-1657. PubMed ID: 33469712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Hyporegenerative Anemia Complicating Hemolytic Disease of the Newborn Secondary to Rhesus Alloimmunization.
    Acosta C; Idris I; Romero R; Ablan L; Montoya Novoa A; Abdalaziz A; Rodriguez A
    Cureus; 2021 Nov; 13(11):e19603. PubMed ID: 34926072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti-D from maternal RhIG.
    Cohen DN; Johnson MS; Liang WH; McDaniel HL; Young PP
    Transfusion; 2014 Nov; 54(11):2863-6. PubMed ID: 24826985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of anti-D antibodies in Rh(D) alloimmunized pregnant women, as a predictor of anemia and/or hyperbilirubinemia in their newborn infants.
    Gottvall T; Hildén JO
    Acta Obstet Gynecol Scand; 1997 Sep; 76(8):733-8. PubMed ID: 9348249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rhesus immunization in a rhesus-positive pregnant woman: fetal erythroblastosis caused by the rhesus antibody anti-C].
    Konstantin-Hansen KF; Larsen HL; Hejl M
    Ugeskr Laeger; 1989 Jun; 151(24):1553. PubMed ID: 2506685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question.
    Alaqeel AA
    Pan Afr Med J; 2019; 32():120. PubMed ID: 31223410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
    Moise KJ
    Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe conjugated hyperbilirubinaemia and neonatal haemolysis.
    Allgood C; Bolisetty S
    Int J Clin Pract; 2006 Nov; 60(11):1513-4. PubMed ID: 17073846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of rhesus alloimmunization in the etiology of late fetal death in Maputo.
    Pereira C; Bergström S
    Gynecol Obstet Invest; 1992; 34(3):139-41. PubMed ID: 1427412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates.
    Legler TJ
    Transfus Apher Sci; 2020 Oct; 59(5):102950. PubMed ID: 33004277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic Anemia and Heart Failure Caused by Anti-C and Anti-E Immunization.
    Bilgin H; Eren A; Kara S
    J Coll Physicians Surg Pak; 2016 Jun; 26(6):539-40. PubMed ID: 27353998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome.
    Smits-Wintjens VE; Rath ME; Lindenburg IT; Oepkes D; van Zwet EW; Walther FJ; Lopriore E
    Neonatology; 2012; 101(4):306-10. PubMed ID: 22354012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.